Meta-analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery

Objective To compare outcomes between minimally invasive left internal thoracic artery bypass and percutaneous coronary artery stenting as primary interventions for isolated lesions of the left anterior descending artery. Design Meta-analysis of randomised and non-randomised comparative peer reviewed publications. Data sources Embase, Medline, Cochrane, Google Scholar, and Health Technology Assessment databases (1966-2005). Review methods Studies comparing the two procedures as the primary intervention for isolated left anterior descending artery stenosis were identified and the following extracted: study design, population characteristics, severity of coronary artery disease, cardiovascular risk factors, and outcomes of interest. Results 12 studies (1952 patients) reporting results from eight groups were included: one was a retrospective design, one prospective non-randomised, and six prospective randomised. Meta-analysis of randomised trials showed a higher rate of recurrence of angina (odds ratio 2.62, 95% confidence interval 1.32 to 5.21), incidence of major adverse coronary and cerebral events (2.86, 1.62 to 5.08), and need for repeat revascularisation (4.63, 2.52 to 8.51) with percutaneous stenting. No significant difference was found in myocardial infarction, stroke, or mortality at maximum follow-up between interventions. Conclusions Minimally invasive left internal thoracic artery bypass for isolated lesions of the left anterior descending artery resulted in fewer complications in the mid-term compared with percutaneous transluminal coronary artery stenting.

[1]  D. Veenstra,et al.  Comparative economic analyses of minimally invasive direct coronary artery bypass surgery. , 2003, The Journal of thoracic and cardiovascular surgery.

[2]  C. Tudor-Smith,et al.  Healthy eating in Wales , 1995, BMJ.

[3]  A. B. Prasad,et al.  British National Formulary , 1994 .

[4]  I. Olkin,et al.  Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement , 1999, The Lancet.

[5]  G. Montalescot,et al.  Drug eluting stents: an updated meta-analysis of randomised controlled trials , 2005, Heart.

[6]  M. Drummond,et al.  Health Care Technology: Effectiveness, Efficiency and Public Policy@@@Methods for the Economic Evaluation of Health Care Programmes , 1988 .

[7]  F. Crea,et al.  A comparison of coronary artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery: five year clinical follow up , 2004, Heart.

[8]  K. Jolly,et al.  Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review. , 2000, Health technology assessment.

[9]  W. Weintraub,et al.  Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST) , 2000, Journal of the American College of Cardiology.

[10]  W Rutsch,et al.  Continued benefit of coronary stenting versus balloon angioplasty: five-year clinical follow-up of Benestent-I trial. , 2001, Journal of the American College of Cardiology.

[11]  R. Peto,et al.  Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.

[12]  J. Ioannidis,et al.  Issues in comparisons between meta-analyses and large trials. , 1998, JAMA.

[13]  George Davey Smith,et al.  Misleading meta-analysis , 1995, BMJ.

[14]  C. Normand,et al.  A systematic review of the role of bisphosphonates in metastatic disease. , 2004, Health technology assessment.

[15]  David O. Williams,et al.  ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary , 2001 .

[16]  A. Kastrati,et al.  Late restenosis in patients receiving a polymer-coated sirolimus-eluting stent. , 2005, Annals of internal medicine.

[17]  D. Heitjan,et al.  Fieller's method and net health benefits. , 2000, Health economics.

[18]  D. Loulmet,et al.  Results of the prospective multicenter trial of robotically assisted totally endoscopic coronary artery bypass grafting. , 2006, The Annals of thoracic surgery.

[19]  A. Culyer,et al.  Community provision of hearing aids and related audiology services. , 2000, Health technology assessment.

[20]  P W Serruys,et al.  Continued benefit of coronary stenting versus balloon angioplasty: one-year clinical follow-up of Benestent trial. Benestent Study Group. , 1996, Journal of the American College of Cardiology.

[21]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.

[22]  Y. Suda,et al.  Partial median sternotomy as a minimal access for off-pump coronary artery bypass grafting: feasibility of the lower-end sternal splitting approach. , 2001, The Annals of thoracic surgery.

[23]  L. Fisher,et al.  Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry). , 1995, Journal of the American College of Cardiology.

[24]  B. Goh,et al.  Integrating pharmacy into the primary care team , 1995, BMJ.

[25]  V. Poyen,et al.  Indications of coronary angioplasty and stenting in 2003: what is left to surgery? , 2003, The Journal of cardiovascular surgery.

[26]  F. Sellke,et al.  Mortality and myocardial infarction following surgical versus percutaneous revascularization of isolated left anterior descending artery disease: a meta-analysis. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[27]  P. Serruys,et al.  The ARTS study (Arterial Revascularization Therapies Study). , 1999, Seminars in interventional cardiology : SIIC.

[28]  D. Fischman,et al.  One-year follow-up of the Stent Restenosis (STRESS I) Study. , 1998, The American journal of cardiology.

[29]  M. Briel,et al.  Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. , 2006, European heart journal.

[30]  Paul Kind,et al.  EQ-5D concepts and methods : a developmental history , 2005 .

[31]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[32]  T. Athanasiou,et al.  Recent advances in minimal-access cardiac surgery using robotic-enhanced surgical systems , 2004, Expert review of cardiovascular therapy.

[33]  Sc Smith ACC/AHA guidelines for percutaneous coronary intervention , 2001 .

[34]  A E Ades,et al.  Evidence synthesis, parameter correlation and probabilistic sensitivity analysis. , 2006, Health economics.

[35]  A H Briggs,et al.  Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. , 1997, Health economics.

[36]  Diana B. Petitti,et al.  Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis: Methods for Quantitative Synthesis in Medicine , 1994 .

[37]  Bari Investigators Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. , 2000, Journal of the American College of Cardiology.

[38]  I. Olkin,et al.  Improving the Quality of Reports of Meta-Analyses of Randomised Controlled Trials: The QUOROM Statement , 2000, Oncology Research and Treatment.

[39]  U. Kappert,et al.  Technique of closed chest coronary artery surgery on the beating heart. , 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[40]  D. Torgerson,et al.  Bootstrapping: estimating confidence intervals for cost-effectiveness ratios. , 1999, QJM : monthly journal of the Association of Physicians.

[41]  B. Gersh,et al.  Controversies in stable coronary artery disease , 2006, The Lancet.

[42]  D. Owens,et al.  Cost-effectiveness of bypass surgery versus stenting in patients with multivessel coronary artery disease. , 2003, The American journal of medicine.

[43]  D J Rowlands,et al.  A multi-centre randomised controlled trial of minimally invasive direct coronary bypass grafting versus percutaneous transluminal coronary angioplasty with stenting for proximal stenosis of the left anterior descending coronary artery. , 2004, Health technology assessment.